USPTO serial 99492774
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason R. Wachter
Jason R. Wachter Gottlieb, Rackman & Reisman P.C.270 Madison Avenue, Suite 1403New York, NY 10016United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | active chemical ingredients for use in the manufacture of pharmaceuticals; carbohydrates used as an ingredient in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of medicines | ACTIVE | — |
| 005 | clinical diagnostic reagents for medical purposes; contrast media for in vivo imaging; contrast media for use with medical imaging equipment; diagnostic agents for medical use in in vivo scanning; imaging agents for magnetic resonance imaging (MRI); medical imaging contrast media; radio-isotope markers for diagnostic use; radiopharmaceutical agents for use in amyloid pathology detection; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radiopharmaceutical preparations for diagnostic purposes; surgical dyes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 11, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 11, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 10, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |